# DESCRIPTION

## FIELD OF THE INVENTION

## BACKGROUND TO THE INVENTION

## STATEMENT OF INVENTION

## Materials and Methods

### Bacterial Strains and Plasmids

### Cloning, Sequencing and Expression of the F. Tularensis O Antigen Coding Region

### Production and Purification of Glycoconjugate Vaccine

### Immunoblot Analysis

### Cytokine Response Analysis

### BALB/c Mouse Challenge Studies

### Statistical Analysis

## Production and Purification of Glycoconjugate Vaccine

### Protein Expression

## EXAMPLE 1

### Expression of the F. tularensis SchuS4 O-Antigen in E. coli DH5Î± Cells

## EXAMPLE 2

### CjPgIB can Transfer F. tularensis O-Antigen to the Acceptor Protein Exotoxin A

## EXAMPLE 3

### Vaccination with the Glycoconjugate Provides Significant Protection Against F. tularensis Subsp. Holarctica Infection in Mice

## EXAMPLE 4

### Mice Vaccinated with Test Glycoconjugate and Challenged with F. tularensis Subsp. Holarctica have Lower Bacterial Loads and Pro-Inflammatory Cytokines 3 Days Post Challenge

### EXAMPLE 5

